ARTICLE | Product Development

Letter from the Editor: Evidentiary standards may be entering a much-needed new era

A series of articles showcases innovation in tools and standards for generating evidence to support new therapies

November 4, 2023 12:52 AM UTC

All CEOs, all heads of R&D, all drug developers center their strategies around the central question: what is the level of evidence we need to get our therapy approved?

While the question has been around for as long as the industry, the answer is continually changing. ...